Patent Update: Thrombin Inhibitors
- 1 September 1992
- journal article
- Published by Informa Healthcare in Current Opinion on Therapeutic Patents
- Vol. 2 (9), 1457-1466
- https://doi.org/10.1517/13543776.2.9.1457
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992
- Anticoagulant activity of a peptide boronic acid thrombin inhibitor by various routes of administration in ratsPeptides, 1991
- Refined structure of the Hirudin-thrombin complexJournal of Molecular Biology, 1991
- Antiplatelet and anticoagulant therapy during coronary thrombolysisTrends in Cardiovascular Medicine, 1991
- The Structure of a Complex of Recombinant Hirudin and Human α-ThrombinScience, 1990
- Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-HJournal of Medicinal Chemistry, 1990
- Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediatesBiochemistry, 1989
- Biology of Recombinant Hirudin (CGP 39393): A New Prospect in the Treatment of ThrombosisSeminars in Thrombosis and Hemostasis, 1989
- INHIBITION OF THROMBIN AND TRYPSIN BY TRIPEPTIDE ALDEHYDESInternational Journal of Peptide and Protein Research, 1978
- IV. On the action of a secretion obtained from the medicinal leech on the coagulation of the bloodProceedings of the Royal Society of London, 1883